The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
HIV & AIDS
Tick (check) box to add article to PDF "basket"
An EU-funded project developed a simple, affordable and effective vaccine strategy to prevent the incidence of both hepatitis C virus and HIV-1. This could significantly increase the life expectancy of people receiving antiretroviral therapy for HIV-1.
Published: 27 July 2018
Do people living with HIV age more quickly, despite the fact that their infection is well controlled? Concerns have emerged in recent years, and an EU-funded study was launched to look into the matter by exploring links with age-related conditions, with a specific focus on cognitive impairment. No acceleration was observed.
Published: 1 December 2017
The weakened immune system in people with HIV/AIDS makes them particularly vulnerable to fungal infections such as cryptococcal meningitis, which can be deadly. The medicine used to treat the condition is flucytosine, and EU-funded researchers have developed a new and more efficient way of producing it. This will cut production costs, making it more affordable for people in low-income countries.
Published: 26 April 2017
A weakened immune system makes HIV-positive women particularly vulnerable to persistent human papillomavirus (HPV) infections, which can lead to cervical cancer. With patchy screening, cervical cancer rates in Africa are especially high. Simple HPV screening could help save lives, an EU-funded project found.
Published: 4 October 2016
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
Published: 20 July 2016
EU-funded project EuroCoord has advanced scientific understanding of HIV by bringing together patient data collected by over 100 institutions. The data are being mined for insight into better prevention and treatment strategies, including for vulnerable groups such as migrants and refugees.
Published: 24 June 2016
Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across the world in a focused effort to develop protective and therapeutic HIV vaccines.The EAVI2020 consortium unites scientists from 22 institutions, pooling their knowledge and expertise to develop novel candidate vaccines that can be taken through to human trials within five years.
Published: 2 March 2016
New vaccines could be developed more quickly and be better targeted to specific age groups, thanks to EU-funded research. A five-year project has been studying novel immunisation technologies, boosting international efforts in vaccine research.
Published: 16 February 2016
Mankind has been at war with mosquitoes down through the ages because of the threat they pose through malaria. ""I've been in the business of mosquitoes for the last 22 years, studying these insects not only because they are fascinating, but also because they cause a lot of trouble in the world through diseases like malaria, which still every year cause the death of more than 700,000 people worldwide," says Bart Knols, a medical entomologist.
Published: 2 April 2015
The AIDS pandemic has claimed the lives of nearly 40 million people. Another 35 million are living with HIV. Scientists around the world however are getting closer to creating a vaccine that could prevent or eliminate the infection. In this program, we go to the forefront of the war against AIDS.
Published: 19 March 2015